1. P2Y2R-Mediated PAK1 Activation Is Involved in ESM-1 Overexpression in RT-R-MDA-MB-231 through FoxO1 Regulation
   Hana Jin et al, 2022, Cancers CrossRef
2. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
   Xuhui Bao et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
3. Cell-type-specific role of P2Y2 receptor in HDM-driven model of allergic airway inflammation
   Dominik Schneble et al, 2023, Frontiers in Immunology CrossRef
4. NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
   Margherita Sonnessa et al, 2020, Frontiers in Oncology CrossRef
5. Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2
   Shilpa Sharma et al, 2021, Frontiers in Pharmacology CrossRef
6. Assessment of NLRP3 inflammasome activation in patients with chronic obstructive pulmonary disease before and after lung transplantation
   Lada Rumora et al, 2024, Immunologic Research CrossRef
7. Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
   Hana Jin et al, 2021, Cancers CrossRef
8. Autocrine and paracrine purinergic signaling in the most lethal types of cancer
   M. Reyna-Jeldes et al, 2021, Purinergic Signalling CrossRef
9. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
   Concetta Saponaro et al, 2021, Frontiers in Oncology CrossRef